Poster Poster Program Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Epidseg-Net:the Multi-Modal Fusion Framework Based on Drr Guidance In Radiotherapy Is Used for Precise Segmentation of Epid Lung Targets

Abstract
Purpose

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture features and a Swin-Transformer branch for capturing global semantic features.

Methods

The model first calibrates multimodal input features through a Dual Attention Mechanism (DAM) to adaptively adjust modality-specific weights, thereby enhancing tolerance to missing image information in multi-sequence segmentation. Subsequently, two key modules are implemented within the multi-scale feature layer: a Large-Kernel Grouped Attention Gating (LKG-Gate) module to strengthen local contextual awareness, and a Multi-Path Feature Extraction (MPFE) module to improve feature robustness via a parallel structure. These designs enable the model to effectively focus on lung tumor target regions, optimize segmentation accuracy, and achieve high-performance reconstruction.

Results

The framework effectively integrates multimodal features, enabling high-precision localization and sharp boundary delineation while preserving anatomical details. Quantitative evaluations demonstrate superior performance: DICE = 93.2 (92.4~93.9), CE = 0.352, HD95 = 9.42 (6.03~12.8), IOU = 86.0 (84.1~87.9), and SENCE = 0.828. Overall, the model excels at preserving gradient information, regional integrity, and fine details; effectively suppresses feature loss; and reduces missed segmentation rates, leading to improvements in both subjective and objective performance metrics.

Conclusion

The proposed segmentation method effectively integrates information from EPID and DRR images, enabling more precise localization and segmentation of lesion regions within EPID images while enhancing segmentation accuracy.

People

Related

Similar sessions

Poster Poster Program
Jul 19 · 07:00
Adverse Events in Targeted Radionuclide Therapy

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Harrison L. Agordzo
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Development of a Web-Based Theranostic Workflow Management Tool

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Ling Zhuang, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Voxel-Wise Dose Heterogeneity Following Yttrium-90 Glass Microsphere Radioembolization In HCC: Association with Pretreatment Tc-99m Maa SPECT/CT Tumor-to-Normal Ratio

Tumor-to-normal ratio (TNR) derived from pretreatment Tc-99m MAA SPECT/CT is widely used as a surrogate marker of perfusion in yttrium-90 (⁹⁰Y) radioembolization for patients with hepatocellular carcinoma (HCC). Delivered activit...

Xinyi Li
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested